Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699498 | Clinical Oncology | 2010 | 6 Pages |
Abstract
This study shows that safe dose escalation to a dose of 60Â G y to skull base lesions can be achieved; using either mMLC- or helical tomotherapy-based IMRT. A plan comparison between the two solutions is difficult, but they seem to be similar in efficacy with any small differences being difficult to interpret and of questionable clinical significance. Helical tomotherapy has the advantage of a significantly decreased beam-on time.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
V. Estall, J. Fairfoul, R. Jena, S.J. Jefferies, K.E. Burton, N.G. Burnet,